Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
36 hedge funds and large institutions have $3.43M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.
10% less funds holding
Funds holding: 40 → 36 (-4)
11% less capital invested
Capital invested by funds: $3.85M → $3.43M (-$421K)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWS
Atria Wealth Solutions
New York
|
+$210K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$125K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76K |
| 4 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
+$39.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$239K |
| 2 |
D.E. Shaw & Co
New York
|
-$168K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$167K |
| 4 |
Renaissance Technologies
New York
|
-$137K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$84.4K |
SRGA Hedge Fund Activity: Q3 2022 in Review
36 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2022, worth a combined $3.43M — down 11% from $3.85M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SRGA and 3 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Atria Wealth Solutions, adding an estimated $210K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $239K sold.
- 36 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2022, down from 40 in Q2 2022.
- Funds reported $3.43M of Surgalign Holdings, Inc. Common Stock stock for Q3 2022, down 11% quarter-over-quarter.
- 3 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2022 and 7 closed out, a net change of -4 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2022 was Atria Wealth Solutions, an estimated $210K added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2022 was Alyeska Investment Group, an estimated $239K sold.
Based on aggregated 13F filings for Q3 2022.